Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.
U.S. stocks rose on Thursday after President Trump raised hopes of a resolution to the Ukraine war and then later put off a decision on additional tariffs on foreign goods. In an interview with The ...
Explore the global efforts of International Childhood Cancer Day, focusing on addressing challenges, inspiring action, and ...
The appearance of a group of people carrying Nazi symbols and signs bearing white supremacist language in Evendale is ...
In the ever-evolving world of hair color, moody gray highlights have emerged as a refreshingly sophisticated alternative to ...
The Savannah Performing Arts Festival kicked off Monday minus one major sponsor and organizers are now appealing to lovers of ...
CSP talks with convenience-store experts on maintaining ‘an organized, well thought-out merchandising customer experience’ ...
The FoodMarble Aire 2 claims to be able to use breath-testing to track gut issues -- but does it really help track down gut ...
A decade into development, the world’s top container orchestrator is more extensible than ever. But usability is still ...
Local company Half Moon Plumbing is featuring different couples from all over Green Country on their billboards for Valentine ...
From diagnosis to treatment, a speaker at the Masters of Pediatric Dermatology conference discussed updates for treating vascular birth marks in infants.In an interview with Healio, Mercedes E.